Infliximab for treating moderate to severe plaque psoriasis

  • Technology appraisal guidance
  • TA134
  • Published: 
Download guidance (PDF)

8 Update information

November 2025: We have made minor editorial changes to the wording in section 1.1 to align with the NICE guideline on psoriasis: assessment and management. This does not affect the meaning or intent of the guidance.

March 2014: Implementation section updated to clarify that infliximab is recommended as an option for treating plaque psoriasis.

ISBN: 978-1-4731-7076-6